Alerts
4371 total results. Page 129 of 175.
Timothy J. Feighery, Lee M. Caplan
Monthly Wrap: News, insights & analysis from Arent Fox's International Arbitration team.
Stephanie Trunk
On July 24, 2018, the United States Court of Appeals for the Fourth Circuit denied the State of Maryland’s petition for an en banc rehearing of the Fourth Circuit’s April 13, 2018 decision in the matter of Association of Accessible Medicines v. Frosh.
The General Data Protection Regulation, commonly referred to as the "GDPR," has been in force for only two months now, but it appears to have already claimed a casualty.
George P. Angelich, Annie Y. Stoops
The Ninth Circuit held that a bankruptcy court may not designate claims (i.e. disqualify claims for plan voting purposes) for bad faith under 11 USC § 1126(e)
Karen Ellis Carr, Stanley H. Abramson, Alexander H. Spiegler
Earlier this week the Court of Justice of the European Union, the EU’s highest court, issued a decision clarifying whether the EU would regulate products of innovative breeding techniques, like gene editing, under the EU’s Directive 2001/18, the principal EU law governing the regulation of GMOs.
Bradford C. Frese
In WesternGeco LLC v. ION Geophysical Corp., the Supreme Court recently held that patent holders can recover lost foreign profits for patent infringement under 35 U.S.C. § 271(f).
Caroline Turner English
The Third Circuit recently affirmed the enforceability of “anti-assignment” provisions in ERISA health plan documents.
Dan H. Renberg, Philip S. English*
On July 24, 2018, the House of Representatives approved 283-132 a bill (H.R. 184, the Protect Medical Innovation Act of 2017) to repeal the excise tax on the sale of a medical device by the manufacturer, producer, or importer.
Lynn R. Fiorentino
Following the US Supreme Court’s narrow ruling in Carpenter v. United States, 585 US ___ (2018) questions have arisen regarding whether this interpretation would remain limited or be expanded in future privacy disputes that came before the High Court.
Thomas E. Jeffry, Jr., Douglas A. Grimm
In a decision that all hospitals should be aware of, on July 9, 2018, the Tenth Circuit reversed a lower court’s dismissal of a False Claims Act case against a physician and two hospitals based on allegations that the physician’s procedures were not medically necessary or reasonable.
Emily Cowley Leongini
California recently announced policy drawing lines between permitted and prohibited sources of cannabinol in products intended to be eaten.
Kay C. Georgi
Most US and multi-national corporations are quick to say, “we don’t do business with North Korea.” However, some companies will recognize the risk of sourcing products from businesses located outside North Korea that may use North Korean overseas workers or subcontract to North Korean companies. The
At first glance, one might conclude that the U.S. Supreme Court’s decision in South Dakota v. Wayfair would have an immediate impact only on those out-of-state vendors that sell goods and services into South Dakota.
Henry Morris, Jr.
In March 2016, the US Department of Labor issued its “Persuader Rule,” reversing a decades-old interpretation of the Labor Management Reporting and Disclosure Act : Under the old interpretation, personal interactions with employees done by employer consultants trigger reporting obligations.
Stephanie Trunk
The Revisions to Payment Policies under the Physician Fee Schedule and Other Revisions to Part B for CY 2019 Proposed Rule (the Proposed Rule) is scheduled to be published in the Federal Register on July 27, 2018.
Henry Morris, Jr.
Nurses, home health aides, personal care attendants, and other home healthcare providers have enabled countless clients to remain in their homes and avoid institutionalization.
Diana Dimitriuc Quaia, Birgit Matthiesen
On July 18, 2018, Secretary of Commerce Wilbur Ross announced the initiation of a Section 232 investigation into the impact of uranium imports on America’s national security.
With its decision in South Dakota v. Wayfair, the US Supreme Court substantially eliminated the distinction between brick-and-mortar business and e-commerce, for purposes of state laws obligating sellers to collect and remit sales taxes.
Stephanie Trunk
On Friday, July 13, 2018, the California Office of Statewide Health Planning and Development (OSHPD) posted proposed regulations implementing California’s drug price transparency law.
As the most recent state to address the issue of what to do with unused medications, on July 10, 2018, New York Governor Andrew Cuomo signed the Drug Take Back Act (the Act).
Robert K. Carrol
Immigration officials have been dramatically increasing inspections in California in 2018 at workplaces ranging in size from small convenience stores to large agricultural operations.
Karen Ellis Carr, Stanley H. Abramson, Katie Heilman
The United States Department of Agriculture and the Food and Drug Administration have recently initiated processes to evaluate and propose revisions to their approaches to the regulation of products of agricultural biotechnology.
On July 11, 2018, the House Energy and Commerce Subcommittee on Communications and Technology held a hearing titled “Protecting Customer Proprietary Network Information in the Internet Age.”
David R. Hamill, Nancy A. Noonan, John Gurley, Kay C. Georgi, Leah Scarpelli, Antonio J. Rivera
On July 6, 2018, the implementation day for the Section 301 “List 1” duties, the United States Trade Representative released the procedures for filing exclusion requests for List 1 products subject to the 25 percent tariff pursuant to Section 301 of the Trade Act of 1974.
On June 28, 2018, the Securities and Exchange Commission (SEC) voted to amend the definition of “smaller reporting company” to allow more companies to use the scaled disclosure requirements available to smaller reporting companies.